Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.66 USD | -3.05% | +1.39% | -26.36% |
05-02 | PDS Biotechnology Corporation Appoints Stephan Toutain as Chief Operating Officer | CI |
03-28 | B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.36% | 138M | |
+2.89% | 106B | |
+7.02% | 23.47B | |
-14.75% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.59% | 16.78B | |
+6.60% | 14.41B | |
+34.70% | 12.86B | |
+317.46% | 8.78B |
- Stock Market
- Equities
- PDSB Stock
- News PDS Biotechnology Corporation
- B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating